334 related articles for article (PubMed ID: 8066357)
1. [Hypercholesterolemia: to treat or not to treat? That is the question].
Ducobu J
Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
Marchioli R; Marfisi RM; Carinci F; Tognoni G
Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
[TBL] [Abstract][Full Text] [Related]
3. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
4. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].
Simoons ML; Casparie AF
Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223
[TBL] [Abstract][Full Text] [Related]
5. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
6. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
Carneiro AV; Costa J; Borges M
Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
[TBL] [Abstract][Full Text] [Related]
7. [Current developments in prevention of coronary heart disease].
Windler E
Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
[TBL] [Abstract][Full Text] [Related]
8. [Evidence of the efficacy of hypocholesterolemic treatment in primary and secondary prevention of ischemic heart disease].
Alvarez-Sala Walther LA; Millán Núñez-Cortés J
Med Clin (Barc); 2000; 114 Suppl 2():1-10. PubMed ID: 10916798
[TBL] [Abstract][Full Text] [Related]
9. [Meta-analysis of therapeutic trials of primary prevention in ischemic cardiopathies by hypocholesteremic treatment].
Cucherat M; Boissel JP; Collet JP
Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():105-8. PubMed ID: 1285686
[TBL] [Abstract][Full Text] [Related]
10. Prevention of coronary heart disease through cholesterol reduction.
Grundy SM
Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
12. [Trials of primary prevention by diet or hypolipidemic treatment].
Richard JL
Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():97-103. PubMed ID: 1285703
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study).
Mizuno K; Nakaya N; Ohashi Y; Tajima N; Kushiro T; Teramoto T; Uchiyama S; Nakamura H;
Circulation; 2008 Jan; 117(4):494-502. PubMed ID: 18172039
[TBL] [Abstract][Full Text] [Related]
14. The benefit of cholesterol-lowering medications after coronary revascularization: a population study.
Brophy JM; Brassard P; Bourgault C
Am Heart J; 2005 Aug; 150(2):282-6. PubMed ID: 16086931
[TBL] [Abstract][Full Text] [Related]
15. [Is there a relationship between cholesterol reduction, low levels of cholesterol and mortality?].
LaRosa JC
Rev Esp Cardiol; 1995; 48 Suppl 2():14-7. PubMed ID: 7569270
[TBL] [Abstract][Full Text] [Related]
16. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
17. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
18. Controversies in primary prevention among hyperlipidemic patients.
McPherson R
Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678
[TBL] [Abstract][Full Text] [Related]
19. Reduction of cholesterol in Kentucky--a state at high risk.
Whayne TF; Zielke JC
J Ky Med Assoc; 2000 Jun; 98(6):248-53. PubMed ID: 10870339
[TBL] [Abstract][Full Text] [Related]
20. [Blood cholesterol and mortality].
Richard JL; Bruckert E; Delahaye F; Emmerich J; Thomas D
Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():11-9. PubMed ID: 1296541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
